ArticleLiver cancer2024

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.

Young Shin Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.